[1]
Y. Thewjitcharoen, “Real-World Use of Once-Weekly Semaglutide in Thai Patients with Type 2 Diabetes Mellitus in a Private Hospital Setting”, J ASEAN Fed Endocr Soc, vol. 38, no. 1, pp. 21–28, Mar. 2023.